Prognostic value of microsatellite instability determined by immunohistochemical staining of hMSH2 and hMSH6 in urothelial carcinoma of the bladder

APMIS

Volumn 116, Issue 1, 2008, Pages 59-65

  Mylona, E ^a   Zarogiannos, A ^b   Nomikos, A ^a   Giannopoulou, I ^a   Nikolaou, I ^a   Zervas, A ^b   Nakopoulou, L ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Bladder cancer; hMSH2; hMSH6; Immunohistochemistry; Prognosis

Indexed keywords

CASPASE 3; PROTEIN MSH2; PROTEIN MSH6; PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER CELL; CANCER GRADING; CANCER SURVIVAL; CELL NUCLEUS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL NUCLEUS; DNA MISMATCH REPAIR; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 38849114453     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2008.00760.x     Document Type: Article

References (29)

1. Peltomaki P. DNA mismatch repair and cancer. Mutat Res 2001 488 : 77 85.
2. O'Brien V, Brown R. Signaling cell cycle arrest and cell death through the MMR system. Carcinogenesis 2006 27 : 682 92.
3. Duval A, Hamelin R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res 2002 62 : 2447 54.
4. Liu B, Nicolaides Nc, Markowitz S, Wilson JK, Parsons RE, Jen J, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995 9 : 48 55.
5. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000 342 : 69 77.
6. Kohonen-Corish MR, Daniel JJ, Chan C, Lin BP, Kwun SY, Dent OF, et al. Low microsatellite instability is associated with poor prognosis in stage C colon cancer. J Clin Oncol 2005 23 : 2318 24.
7. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005 3 : 609 18.
8. Kassem HSh, Varley JM, Mamam SM, Margison GP. Imunohistochemical analysis of expression and allelotype of mismatch repair genes (hMLH1 and hMSH2) in bladder cancer. Br J Cancer 2001 84 : 321 8.
9. Christensen M, Jensen MA, Wolf H, Ørntoft TF. Pronounced microsatellite instability in transitional cell carcinomas from young patients with bladder cancer. Int J Cancer (Pred Oncol) 1998 79 : 396 401.
10. Catto J, Xinarianos G, Burton JL, Meuth M, Hamdy FC. Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability. Int J Cancer 2003 105 : 484 90.
11. Leach FS, Hsieh JT, Molberg K, Saboorian MH, McConnell JD, Sagalowsky AI. Expression of the human mismatch repair gene hMSH2: a potential marker of urothelial malignancy. Cancer 2000 88 : 233 41.
12. Yamamoto Y, Hatsuyama H, Kawauchi S, Furuya T, Liu XP, Ikemoto K, et al. Biological characteristics in bladder cancer depend on the type of genetic instability. Clin Cancer Res 2006 12 : 2752 8.
13. Jin T-X, Furiahata M, Yamasaki I, Kamada M, Liang S-B, Ohtsuki Y, et al. Human mismatch repair gene (hMSH2) product expression in relation to recurrence of transitional cell carcinoma of the urinary bladder. Cancer 1999 85 : 478 84.
14. Vaish M, Mandhani A, Mittal RD, Mittal B. Microsatlellite instability as prognostic marker in bladder tumors: a clinical significance. BMC Urology 2005 5 : 2 9.
15. Saetta AA, Goudopoulou A, Korkolopoulou P, Voutsinas G, Thomas-Tsagli E, Michalopoulos NV, et al. Mononucleotide markers of microsatellite instability in carcinomas of the urinary bladder. EJSO 2004 30 : 796 803.
16. +tumor cells. Cell 1993 75 : 1227 36.
17. Cawkwell L, Gray S, Murgatroyd H, Sutherland F, Haine L, Longfellow M, et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut 1999 45 : 409 15.
18. Lanza G, Gafa R, Maestri I, Santini A, Matteuzzi A, Cavazzini L. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. Mod Pathol 2002 15 : 741 9.
19. Stone JG, Roberrtson D, Houlston RS. Immunohistochemistry for MSH2 and MLH1: a method for identifying mismatch repair deficient colorectal cancer. J Clin Pathol 2001 54 : 484 7.
20. Eble JN, Souter G, Epstein JI, Sesterhenn IA. Tumors of the Urinary System and Male Genital Organs. World Health Organization Classification of Tumors. Pathology and Genetics. Lyon : IARC Press, 2004.
21. Giannopoulou I, Nakopoulou L, Zervas A, Lazaris AC, Stravodimos K, Giannopoulos A, et al. Immunohistochemical study of pro-apoptotic factors Bax, Fas and CPP32 in urinary bladder cancer: prognostic implications. Urol Res 2002 30 : 342 5.
22. Nakopoulou L, Vourlakou C, Zevas A, Tsonou A, Giakopoulou H, Dimopoulos MA. The prevalence of bcl-2, p53 and Ki67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. Hum Pathol 1998 29 : 146 54.
23. Pavlopoulos PM, Davaris P. Software development for the evaluation of histochemical and immunohistochemical color images. Presented at the 24th Annual Panhellenic Medical Congress : Athens, Greece, May 5-9, 1993.
24. Pavlopoulos PM, Konstantinidou A, Agapitos E, Kavantzas N, Nikolopoulou P, Davaris P. A morphometric study of neovascularization in colorectal carcinoma. Cancer 1998 83 : 2067 75.
25. Parsons R, Li GM, Longley M, Modrich P, Liu B, Berk T, et al. Mismatch repair deficiency in phenotypically normal human cells. Science 1995 268 : 738 40.
26. Hartmann A, Zanardo L, Bocker-Endmonston T, Blaszyk H, Dietmaier W, Stoehr R, et al. Frequent microsatellite instability in sporadic tumors of the upper urinary tract. Cancer Res 2002 62 : 6796 802.
27. de Leeuw WJF, Dierssen JW, Vasen HFA, Wijnen J, Kenter GG, Meijers-Heijboer H, et al. Prediction of mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumors from HNPCC patients. J Pathol 2000 192 : 328 35.
28. Gonzalez-Zulueta M, Ruppert JM, Tokino K, Tsai YC, Spruck CH 3rd., Miyao N, et al. Microsatellite instability in bladder cancer. Cancer Res 1993 53 : 5620 3.
29. Miquel C, Borrini F, Grandjonan S, Auperin A, Viguier J, Velasco V, et al. A role of bax mutations in apoptosis in colorectal cancers with microsatellite instability. Am J Clin Pathol 2005 123 : 562 70.